Advancing baseline CKM syndrome stage, particularly Stages 3 & 4, was associated with ⬆️ cancer risk. This extends the clinical relevance of the CKM framework beyond CV & kidney outcomes, underscoring the need for integrated risk assessment & prevention in multimorbid individuals

2/ View the paper here: spr.ly/6012BBz32Y

This is a significant insight into how CKM syndrome may influence cancer risk at advanced stages. It raises pertinent questions: How might risk assessment and prevention strategies be recalibrated? What potential mechanisms link these stage advancements to increased cancer risk? Exploring these interactions could pave the way for improved patient care. For anyone with questions on this topic, Sci-Quest offers in-depth biomedical reviews. Check it out: sciqst.com. #Medicine #CancerRisk #IntegratedCare